Bio-IT

Databases & Data Management

Genedata Releases Genedata Biologics

Genedata Releases Genedata Biologics

2,753 views

San Francisco, CA (Scicasts) - Genedata, a provider of advanced software solutions for drug discovery and life science research, has announced the release of Genedata Biologics, an off-the-shelf software solution for comprehensive data management and analysis of biologics R&D activities.

Unique Database of Cancer Launched

Unique Database of Cancer Launched

2,083 views

Washington, DC (Scicasts) – Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, has announced the launch of the Georgetown Database of Cancer or G-DOC. Under development for two years, G-DOC is a repository for biological information that is normally only available in scattered information libraries and tissue banks, if at all. Data sets grow as researchers deposit new information. G-DOC also contains relevant tools to analyze the data, plus new ones not seen before.

Genedata Releases Genedata Selector

Genedata Releases Genedata Selector

2,135 views

San Francisco, CA (Scicasts) - Genedata, a provider of advanced software solutions for drug discovery and life science research, has announced Genedata Selector, a new solution for biotechnological strain development in fermentation-based applications. The latest addition to the Genedata portfolio, Genedata Selector is an integrated data management and analysis system specifically for industrial biotechnology R&D. It supports industrial biotechnology production of feed and food additives, fine chemicals, biofuels, and personal care, pharmaceutical, and agrochemical products.

TreeBASE Provides Latest Information on Evolution

TreeBASE Provides Latest Information on Evolution

3,403 views

Durham, NC (Scicasts) - If scientists have identified some two million species, where can you find the latest information about the tree of life that unites them all? According to a report from National Evolutionary Synthesis Center (NESCent) in Durham, North Carolina, an improved database gives scientists and educators access to state-of-the-art knowledge about the evolutionary relationships among living things.

EMBL-EBI Launches Open Access Drug Discovery Database

EMBL-EBI Launches Open Access Drug Discovery Database

2,715 views

Hinxton and London (Scicasts) - ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launched earlier this week with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

SPRESI Reaction Database Joins Symyx Reaction Databases

SPRESI Reaction Database Joins Symyx Reaction Databases

3,378 views

Sunnyvale, CA (OBBeC) - Symyx Technologies has announced that the SPRESI structure and reaction database from InfoChem GmbH is now available to chemists via the Symyx Isentris data access, analysis, and decision support system. In combination with existing Symyx reaction databases, which provide extensive coverage of reactions, detailed experimental methodology, and links to online citations and in-house reaction data, the SPRESI database offers synthesis chemists a high quality and cost-effective synthesis planning solution.
Georgetown University Medical Centre Collaborates with Indivumed to Develop Cancer Research Database

Georgetown University Medical Centre Collaborates with Indivumed to Develop Cancer Research Database

2,548 views

Washington, DC (OBBeC) - Georgetown University Medical Centre has announced an agreement with Indivumed GmbH, based in Hamburg, Germany, which provides the foundation for the analysis of complex clinical molecular signatures from cancer patients, enabling researchers and physicians to better diagnose and tailor cancer treatments for individual patients.

This arrangement builds upon a one-year agreement currently in place at Georgetown that established a tumour biobank and clinical database for pancreatic cancer and which now also includes cancer of the breast and colon.



The expanded collaboration will grow to include a clinical database of prostate, glioblastoma and renal cancer. Together, the institutions will work to establish a robust portfolio of research collaborations, supported by a state-of-the-art biobanking infrastructure and protocol, using Indivumed’s established scientific approach, and a multidimensional, integrated clinical and molecular database of cancer.



“Integrating scientific, medical, and technological expertise and assets will transform our ability to analyze complex clinical data relating to specific diseases, employing a more comprehensive, system-level approach to how we treat patients,” says Dr Howard J Federoff, Executive Vice President for Health Sciences at GUMC. “We’re starting with cancer, and hope this kind of research will lead to better, more individually targeted treatments.”



The agreement will expand upon the Indivumed biobank protocol already begun at Georgetown University Hospital, expanding the collection, storage, analysis and utilization of biospecimens. This includes prospective and standardized collection of pre-, intra- and post-surgical patient data and biospecimen data by specially trained research associates, extracting clinical data from existing clinical systems, developing an enhanced collaborative relationship with the MedStar Health system, which owns and operates Georgetown University Hospital through a clinical partnership agreement with the university, and eventually developing partnerships with national health systems to establish a network of biobanking partnerships for specimen collection.



“Indivumed’s approach to standardized and high-quality biobanking and data management as a foundation for individualized medical treatment aligns well with GUMC’s approach to a database of cancer,” says Dr Hartmut Juhl, CEO of Indivumed and former GUMC faculty member.



According to the announcement, the collaboration is a key step in the future development of the Georgetown Database of Cancer (G-DOC) at Lombardi Comprehensive Cancer Centre at Georgetown. The G-DOC will be designed to marry clinical information from patients in clinical trials with molecular characteristics of their cancer. This effort will define the molecular features that underlie prognosis and responsiveness to therapy in patients, providing a basis for personalized medicine and a tool for target discovery and drug development.

Applied Biosystems and Integromics Develop Data Analysis and Management Platform

Applied Biosystems and Integromics Develop Data Analysis and Management Platform

1,995 views

Warrington, UK (OBBeC) - Applied Biosystems and Integromics, a scientific IT company, have announced that they have developed a fully integrated, large-scale data management and analysis platform, together with Novartis Pharma. The platform, according to the companies, combines advanced bioinformatics software with high throughput real-time PCR systems in order to analyze large volumes of real-time gene expression data, such as those produced for biomarker analysis in drug development or clinical studies.  

According to the announcement, The platform integrates the Integromics Real-Time StatMiner software with the Applied Biosystems’ line of real-time PCR systems and TaqMan Arrays. Raw data are captured from these technologies and analyzed using the StatMiner software’s combination of interactive data visualization tools, advanced statistical analysis and data mining.
 
The collaboration has resulted in a fully integrated platform for seamless analysis of real- time gene expression data produced during biomarker analysis. The new system eliminates the need for multiple applications and interfaces, and allows gene expression data analysis to be performed in a unique secure environment.  

The StatMiner software provides sophisticated statistical analysis tools that are presented in a user-friendly format, making them accessible even to non-bioinformatics experts. The report outlines that  the software is particularly useful for identifying outliers and features valuable normalization capabilities.

“This marks an important step towards consolidating real-time PCR as a method for analyzing gene expression biomarkers in pharmaceutical and clinical research,” said Xavier Cristina, Applied Biosystems’ European manager for business development in functional analysis. “Working in collaboration with Integromics, we have created a solution that supports our mutual customers such as Novartis in their gene expression research, by enabling them to turn their data into meaningful information for use in a range of research projects including drug discovery and development.”  
Database of Human Oral Microbiome Launched

Database of Human Oral Microbiome Launched

3,415 views

Bethesda, MD. (OBBeC) - Grantees of the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, and their international colleagues have launched the first comprehensive database of the oral microbiome, or the approximately 600 distinct microorganisms currently known to live in the mouth.

The free online compendium is called the Human Oral Microbiome Database (HOMD). The database, which went live yesterday as the digital equivalent of an Oxford dictionary of oral microorganisms, provides detailed biological entries for each species and an extensive catalogue of the thousands of genes that these microbes express. The site is located at http://www.homd.org and is overseen by scientists at The Forsyth Institute in Boston and King’s College London in England.

“The HOMD fills a critical research need,” said NIDCR director Dr Lawrence Tabak. “The oral microbiome is extremely rich in data, and HOMD becomes the essential search engine for scientists to view and retrieve this information, generate novel hypotheses, make computational discoveries, and ultimately develop more biologically sound therapies to control oral diseases.”

According to Dr Floyd Dewhirst, a leader of the project and a scientist at The Forsyth Institute, HOMD also introduces the first comprehensive nomenclature system to bring order to the naming of uncultured or previously unnamed oral microbes. The standardized numbering system helps to eliminate the Babel of confusing names and uninformative database designations that have frustrated scientists and sometimes hindered their research.

The database also categorizes each microbe by its 16S rRNA sequence, a distinctive fingerprint of genetic information that scientists have used for the past two decades to identify microorganisms. This sequence information allows the microbes to be placed in a family tree that shows how they are related to one another. For those organisms whose DNA has been sequenced, HOMD provides online tools to view and analyze all of their genes and proteins. Each category of information in the database is interlinked, readily searchable, appropriately annotated, and will be frequently updated to remain current.

Dewhirst noted that although HOMD has officially opened to scientists, the database remains an ongoing project. “We’ve already assembled a great deal of useful information for the research community, but we will continue to expand and refine the database for the next several years,” said Dewhirst. “I can see the Human Oral Microbiome Database serving as a valuable model for other microbiome databases now and in the years to come.”

Informally called “biology’s next revolution,” microbiome studies have opened a needed window into the complex microbial communities that occupy most parts of the human body. These studies will define how microbes contribute to sustaining health and, when their community dynamics are perturbed, play a role in common chronic disease, such as tooth decay and periodontal disease in the mouth. In December 2007, NIH launched the Human Microbiome Project that initially will sequence all of the genes, or genomes, of 600 representative microorganisms sampled from microbial communities in the mouth, skin, digestive tract, nose, and female urogenital tract. Additional studies are either under way or under development.Among those already well under way is a NIDCR-supported project to compile a full catalogue of the complete genomes of all oral microbes. It has generated a tremendous amount of data and, coupled with the decades of more traditional studies of oral bacteria, the need for a comprehensive, user-friendly database has become a priority.

“The oral microbiome is currently better understood than those of other sites in the body, such as the intestine,” said Dr. Bruce Paster, also at The Forsyth Institute and another project scientist. “Since oral microorganisms appear in infections throughout the human body, the HOMD database certainly will be useful to physicians. Likewise, microbiologists in industry will find HOMD helpful because oral microbes sometimes contaminate food or the drug manufacturing process.”

ArrayExpress Database Doubles in Size

ArrayExpress Database Doubles in Size

2,055 views

According to a report from the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI), ArrayExpress, the publicly available database of transcriptomics data  has doubled in size in 2007, reaching the 100,000-hybridisation milestone. The database now holds snapshots of gene expression (identifying which genes are specifically expressed in a particular tissue or in response to a drug, for example) for more than 180 species under thousands of experimental conditions.